---
$id: https://graph.org.ai/products/commodity/51142036
$type: Product
source: UNSPSC
code: "51142036"
title: "Nicoboxil"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nicoboxil

**UNSPSC Code**: 51142036
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an analgesic agent with the molecular formula C12H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GSD5B9US0W, chemically known as 3-pyridinecarboxylic acid, butoxyethyl ester but generally known as nicoboxil, which bears US NIH Compound Identifier 14866. European Medicines Agency schedules Nicoboxil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09231MIG. The term NICOBOXIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). NICOBOXIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicoboxil under HS 29333999 and SITC 51574. As of Q4 2014, NICOBOXIL remains the US FDA Preferred Term for this commodity. Nicoboxil bears US NLM identifiers UMLS ID C0770962 and NCI Concept Code C84007. SMILES: CCCCOCCOC(=O)C1=CN=CC=C1.

